Clinical Trials Logo

Povidone Iodine Adverse Reaction clinical trials

View clinical trials related to Povidone Iodine Adverse Reaction.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04510402 Not yet recruiting - Covid19 Clinical Trials

Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects

Start date: August 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Title: Phase I/II Trial (Safety and Dosing) of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects: Summary: This study will evaluate in a PH I/II trial in healthy volunteers the safety and tolerability of PVP-I nasal swabs daily application. The intent is to follow with a PH III randomized controlled clinical trial to assess the capacity for PVP-I nasal swabs to mitigate the transmission of respiratory viruses specifically COVID 19.